Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT02639923Completed

The Clinical Relevance of Micro RNAs in Mild Traumatic Brain Injury

Role: collaborator

NCT03995823Completed

Evaluation of Nidus Occlusion After Gamma Knife Radiosurgery of Cerebral Arteriovenous Malformations Using Magnetic Resonance Imaging

Role: collaborator

NCT02639780Completed

Biochemical Alterations of Stored Erythrocyte Membranes

Role: collaborator

NCT04356144Completed

Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections

Role: collaborator

NCT02930330Not ApplicableCompleted

Interval Training in Cardiac Rehabilitation

Role: collaborator

NCT02456116Not ApplicableUnknown

Efficiency Study About the Effect of Acupuncture on Postoperative Pain After Total Knee Arthroplasty

Role: collaborator

NCT01682889Phase 4Completed

The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation

Role: lead

NCT01165801Phase 4Completed

Size Progression of Macular Degeneration After Cataract Surgery

Role: collaborator

All 8 trials loaded